Professional
Added to YB: 2025-03-03
Pitch date: 2024-12-31
LEGN [bullish]
Legend Biotech Corporation
+4.35%
current return
Author Info
No bio for this author
Company Info
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe.
Market Cap
$6.3B
Pitch Price
$32.85
Price Target
N/A
Dividend
N/A
Sector
Biotechnology
Category
growth
Meridian Contrarian Fund Added On Portfolio Holding: Legend Biotech Corporation
LEGN added: Developing promising CAR-T cancer drug with J&J. Stock pressured by ex-CEO controversy & China concerns. Competitor fears impacting sales, but our research sees inferior rival. Well-positioned, added on weakness. Biotech team confident in drug potential & J&J partnership.
Read full article (1 min)